ASN
COLL icon

Advisory Services Network’s Collegium Pharmaceutical COLL Stock Holding History

Advisory Services Network’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-325
Closed -$10.7K – 2644
2026
Q1 		$10.7K Buy
+325
New +$13.8K ﹤0.01% 3530
2023
Q2 		– Sell
-2,332
Closed -$55.9K – 1873
2023
Q1 		$55.9K Sell
2,332
-1,145
-33% -$30.4K ﹤0.01% 1967
2022
Q4 		$80.7K Buy
+3,477
New +$70.1K ﹤0.01% 1732
2019
Q2 		– Sell
-6,250
Closed -$95K – 2817
2019
Q1 		$95K Sell
6,250
-5,550
-47% -$88.9K 0.01% 1011
2018
Q4 		$203K Buy
+11,800
New +$202K 0.02% 698

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Advisory Services Network's COLL Position: Q2 2026 in Review

Advisory Services Network sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 325 shares — an estimated $10.7K sold.

Advisory Services Network first reported a position in COLL in Q4 2018 and held it in 5 quarters. The position peaked at $203K in Q4 2018. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Advisory Services Network reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 325 Collegium Pharmaceutical shares in Q2 2026, an estimated $10.7K.
  • Advisory Services Network first reported a position in Collegium Pharmaceutical in Q4 2018 and held it in 5 quarters.
  • Advisory Services Network's Collegium Pharmaceutical position peaked at $203K in Q4 2018.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.